5-Oxo-eicosatetraenoate is a broadly active, eosinophil-selective stimulus for human granulocytes

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 336-342

  O'Flaherty, Joseph T ^a   Kuroki, Mitsuyuki ^a   Nixon, Andrew B ^a   Wijkander, Jonny ^a,b   Yee, Eugenia ^a   Lee, Shelly L ^a   Smitherman, Pamela K ^a   Wykle, Robert L ^a   Daniel, Larry W ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 OXO 6,8,11,14 ICOSATETRAENOIC ACID; ARACHIDONIC ACID; CHEMOTACTIC FACTOR; COMPLEMENT COMPONENT C5A; CYTOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE B4; MITOGEN ACTIVATED PROTEIN KINASE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; DEGRANULATION; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; HYPERSENSITIVITY; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ARACHIDONIC ACIDS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DEGRANULATION; CHEMOTACTIC FACTORS, EOSINOPHIL; ENZYME ACTIVATION; EOSINOPHILS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS;

EID: 0029982657     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Israel, E. 1992. Moderating the inflammation of asthma: inhibiting the production or action of products of the 5-lipoxygenase pathway. Ann. Allergy 72:279.
2. Lemanske, R. F., Jr., and M. A. Kaliner. 1994. Late phase allergic reactions. Allergy 82:320.
3. Pilewski, J. M., and S. M. Albelda. 1995. Cell adhesion molecules in asthma: homing, activation, and airway remodeling. Am. J. Respir. Cell Mol. Biol. 12:1.
4. Resnick, M. B., and P. F. Weller. 1993. Mechanisms of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8:349.
5. Morita, E., J.-M. Schroder, and E. Christophers. 1989. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins. Scand. J. Immunol. 29:709.
6. 4 effects on human eosinophil and neutrophil motility in vitro. J. Leukocyte Biol. 55:183.
7. Ben-Baruch, A., D. F. Michiel, and J. J. Oppenheim. 1995. Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem. 270:11703.
8. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881.
9. Daffern, P. J., P. H. Pfeifer, J. A. Ember, and T. E. Hugli. 1995. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:2119.
10. Erger, R. A., and T. B. Casale. 1995. Comparative studies indicate that plateletactivating factor is a relatively weak eosinophilotactic mediator. Am. J. Respir. Cell Mol. Biol. 22:65.
11. Bruijnzeel, P. L. B., H. M. Kuijper, S. Rihs, S. Betz, R. A. J. Warringa, and L. Koenderman. 1993. Eosinophil migration responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J. Invest. Dermatol. 100:137.
12. Sehmi, R., A. J. Wardlaw, O. Cromwell, K. Kazuyuki, P. Waltmann, and A. B. Kay. 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79:2952.
13. Hakansson, L., and P. Venge. 1994. Priming of eosinophil and neutrophil migratory responses by interleukin 3 and interleukin 5. Acta Pathol. Microbiol. Immunol. Scand. 102:308.
14. Warringa, R. A. J., R. C. Schweizer, T. Maikoe, P. H. M. Kuijper, L. B. Bruijnzeel, and L. Koenderman. 1992. Modulation of eosinophil chemotaxis by interleukin-5. Am. J. Respir. Cell. Mol Biol. 7:631.
15. Rand, T. H. E., W. W. Cruikshank, D. M. Center, and P. F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med. 173: 1521.
16. Rand, T. H. E., D. S. Silberstin, H. Kornfeld, and P. F. Weller. 1991. Human eosinophils express functional interleukin 2 receptors. J. Clin. Invest. 88:825.
17. Leff, A. R. 1994. Inflammatory mediation of airway hyperresponsiveness by peripheral blood granulocytes. Chest 106:1202.
18. Larsen, J. S., and E. P. Acosta. 1993. Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma. Ann. Pharmacother. 27:898.
19. Israel, E., R. Dermarkarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin, and J.-M. Drazen. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Engl. J. Med. 323:1740.
20. Hui, K. P., I. K. Taylor, G. W. Taylor, P. Rubin, J. Kesterson, N. C. Barnes, and P. J. Barnes. 1991. Effect of 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients. Thorax 46: 184.
21. Israel, E., P. Rubin, J. P. Kemp, J. Grossman, W. Pierson, S. C. Siegel, D. Tinkelman, J. J. Murray, W. Busse, A. T. Segal, J. Fish, H. B. Kaiser, D. Ledford, S. Wenzel, R. Rosenthal, J. Cohn, C. Lanni, H. Pearlman, P. Karahalios, and J. M. Drazen. 1993. The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann. Intern. Med. 119:1059.
22. Abraham, W. M., A. Ahmed, A. Cortes, M. W. Zielczak, W. Hinz, J. Bouska, C. Lanni, and R. L. Bell. 1992. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep. Eur. J. Pharmacol. 217:199.
23. Wegner, C. D., R. H. Gundel, W. M. Abraham, E. S. Schulman, M. J. Kontny, E. S. Lazer, C. A. Homon, A. G. Graham, C. A. Torcellini, C. C. Clarke, P. Jager, W. W. Wolyneic, L. G. Letts, and P. R. Farina. 1993. The role of 5-lipoxygenase products in preclinical models of asthma. J. Allergy Clin. Immunol. 91:917.
24. 4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49:230.
25. Powell, W. S., D. Chung, and S. Gravel. 1995. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration. J. Immunol. 1554: 4123.
26. Schwenk, U., and J.-M. Schroder. 1995. 5-Oxo-eicosanoids are potent eosinophil chemotactic factors. J. Biol. Chem. 270:15029.
27. Schwenk, U., E. Morita, R. Engel, and J.-M. Schroder. 1992. Identification of 5-oxo-15-hydroxy-6,8.11,13-eicosatetraenoic acid as a novel and potent human eosinophil chemotactic eicosanoid. J. Biol. Chem. 267:12482.
28. 4 receptor. J. Biol. Chem. 268:9280.
29. O'Flaherty, J. T., J. Cordes, J. Redman, and M. J. Thomas. 1993, 5-Oxo-eicosatetraenoate, a potent human neutrophil stimulus. Biochem. Biophys. Res. Commun. 192:129.
30. O'Flaherty, J. T., J. F. Cordes, S. L. Lee, M. Samuel, and M. J. Thomas. 1994. Chemical and biological characterization of oxo-eicosatetraenoic acids. Biochim. Biophys. Acta 1201:505.
31. Kroegel, C., T. Yukawa, G. Dent, P. Venge, K. F. Chung, and P. J. Barnes. 1989. Stimulation of degranulation from human eosinophils by platelet-activating factor. J. Immunol. 142:3518.
32. DeOlarte, D. G., and J. S. Abramson. 1983. A simplified under-agarose method for measuring neutrophil chemotaxis. J. Infect. Dis. 147:1104.
33. Venge, P. 1993. Eosinophil and neutrophil granulocytes. Allergy 48:39.
34. O'Flaherly, J. T., M. J. Thomas, M. J. Hammett, C. Carroll, C. E. McCall, and R. L. Wykle. 1983. 5-L-Hydroxy-6,8,11,14-eicosatetraenoate potentiates the human neutrophil degranulating actions of platelet-activating factor. Biochem. Biophys. Res. Commun. 111:1.
35. Broide, D. H., M. M. Paine, and G. S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte-macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin. Invest. 90:1414.
36. Miyamasu, M., K. Hirai, M. Takahashi, M. Iida, T. Koshino, T. Takaishi, Y. Monta, K. Ohta, T. Kasahara, and K. Ito. 1995. Chemotactic agonists induce cytokine generation in eosinophils. J. Immunol. 145:1339.
37. Koregel, C., and H. Matthys. 1993. Platelet-activating factor-induced human eosinophil activation. Immunology 78:279.
38. Lee, T., D. J. Lenihan, B. Malone, L. L. Roddy, and S. I. Wasserman. 1984. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J. Biol. Chem. 259:5526.
39. Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14842.
40. Park, J.-H., and L. Levitt. 1993. Overexpression of mitogen-activated protein kinase (ERK1) enhances T-cell cytokine gene expression: role of AP1, NF-AT, and NF-KB. Blood 82:2470.
41. Boulton, T. G., and M. H. Cobb. 1991. Identification of multiple extracellular signal-regulated kinases (ERKs) with anti-peptide antibodies. Cell Regul. 2:357.
42. Rot, A. 1993. Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by a haptotactic mechanism. Eur. J. Immunol. 23:303.
43. Nathan, C. F. 1987. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80:1550.
44. Pazdrak, K. D., D. Schreiber, P. Forsythe, L. Justement, and R. Alam. 1995. The intracellular signal transduction mechanism of interleukin 5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-MEK-microtubule-associated protein kinase pathway. J. Exp. Med. 181:1827.
45. 2. Biochem. J. 308:815.
46. Gasperini, S., M. Donini, S. Dusi, and M. A. Cassatella. 1995. Interleukin-10 decreases tyrosine phosphorylation of discrete lipopolysaccharide-induced phosphoproteins in human granulocytes. Biochem. Biophys. Res. Commun. 209:87.
47. Gonzales, F. A., D. L. Raden, M. R. Rigby, and R. J. Davis. 1992. Heterogeneous expression of four MAP kinase isoforms in human tissues. FEBS Lett. 304:170.
48. 2 in human neutrophils. J. Biol. Chem. 270:26543.
49. O'Flaherty, J. T., and A. G. Rossi. 1993. 5-Hydroxyicosatetraenoate stimulates neutrophils by a stereospecific, G protein-linked mechanism. J. Biol. Chem. 268: 14708.